ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Transformer-Based PET/CT Fusion Enables Preoperative Prediction and Prognostic Stratification of Spread Through Air Spaces in Lung Adenocarcinoma.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Spread through air spaces (STAS) is associated with recurrence and unfavorable outcomes in lung adenocarcinoma, yet reliable preoperative identification remains challenging. This multicenter retrospective study includes 212 patients with 219 tumors across three institutions and develops a transformer-based multimodal framework integrating eight complementary 2.5D PET and CT representations for preoperative STAS risk assessment. The model achieves an area under the receiver operating characteristic curve of 0.822 (95% CI, 0.725-0.920) in the independent external test cohort, with higher discrimination than the evaluated single-modality and conventional fusion approaches. Beyond STAS classification, the continuous model-derived risk score is associated with progression-free survival after adjustment for pathological T stage, N stage, and maximum tumor diameter (HR, 4.24; 95% CI, 1.47-12.25; P = 0.008), although the limited number of progression events warrants cautious interpretation. Exploratory transcriptomic analyses across two public cohorts further nominate candidate programs involving cell adhesion, vesicle trafficking, complement activity, and metabolic remodeling. Together, these findings highlight the potential of multimodal PET/CT fusion to integrate morphological and metabolic information for noninvasive STAS risk stratification and support further prospective multicenter evaluation toward individualized surgical decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.